Get the Stockscreener App
46.35
1.34%
-0.63
After Hours:
46.05
-0.30
-0.65%
Conmed Corp stock is traded at $46.35, with a volume of 509.68K.
It is down -1.34% in the last 24 hours and up +41.61% over the past month.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
See More
Previous Close:
$46.98
Open:
$45.6
24h Volume:
509.68K
Relative Volume:
0.85
Market Cap:
$1.40B
Revenue:
$1.37B
Net Income/Loss:
$54.85M
P/E Ratio:
26.14
EPS:
1.7729
Net Cash Flow:
$123.71M
1W Performance:
+8.60%
1M Performance:
+41.61%
6M Performance:
+20.73%
1Y Performance:
-9.38%
1-Day Range:
$45.24
$46.78
1-Week Range:
$42.70
$49.00
52-Week Range:
$31.44
$56.63
Conmed Corp Stock (CNMD) Company Profile
Name
Conmed Corp
Sector
Industry
Phone
727-214-2974
Address
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
46.35 | 1.31B | 1.37B | 54.85M | 123.71M | 1.7729 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-12-25 | Downgrade | Needham | Buy → Hold |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Feb-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-01-24 | Reiterated | Needham | Buy |
| May-22-23 | Initiated | CL King | Buy |
| Mar-27-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-21-23 | Initiated | Wells Fargo | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Oct-06-21 | Upgrade | Needham | Hold → Buy |
| Jul-15-21 | Initiated | UBS | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| Nov-26-19 | Downgrade | Needham | Buy → Hold |
| Nov-12-19 | Initiated | JP Morgan | Overweight |
| Oct-31-19 | Reiterated | Needham | Buy |
| Oct-04-19 | Reiterated | Needham | Buy |
| Aug-22-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Apr-18-19 | Initiated | Stifel | Buy |
| Apr-16-19 | Reiterated | Needham | Buy |
| Jan-23-19 | Reiterated | Needham | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Aug-07-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Apr-26-18 | Reiterated | Needham | Buy |
| Feb-01-18 | Reiterated | Needham | Buy |
| Jul-27-17 | Reiterated | Needham | Buy |
| Apr-27-17 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-27-17 | Reiterated | Needham | Buy |
| Nov-18-16 | Reiterated | Needham | Buy |
| Jul-28-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-28-16 | Reiterated | Needham | Buy |
| Oct-22-15 | Reiterated | Northland Capital | Market Perform |
View All
Conmed Corp Stock (CNMD) Latest News
Conmed Corp (CNMD) Cash Flow - TradingKey
Conmed Corp (CNMD) Institutional Confidence - TradingKey
Conmed Corp (CNMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Principal Financial Group Inc. Has $7.45 Million Stock Position in CONMED Corporation $CNMD - MarketBeat
Conmed Corp (CNMD) Balance Sheet - TradingKey
Conmed Market Sentiment - Benzinga España
Conmed Corp (CNMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
CONMED Corporation (CNMD) Stock Forecasts - Yahoo Finance
TradingKey - TradingKey
Conmed Corp (CNMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Conmed Corp (CNMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CNMD|Conmed Corp|Price:43.500|Chg%:+0.820 - TradingKey
Conmed Corp (CNMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Conmed Corp (CNMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Electrosurgery Market Projected to Reach $11.59 Billion by 2031 as Demand for Minimally Invasive Procedures Rises - GlobeNewswire Inc.
Conmed Corp (CNMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Conmed Corp (CNMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CONMED Expands AirSeal Robotic Solution for da Vinci 5 Hex Cannula - Zacks Investment Research
Conmed’s AirSeal Robotic Solution OK’ed for Intuitive da Vinci 5 Hex Cannula - Medical Product Outsourcing
CONMED expands AirSeal compatibility to da Vinci 5 platform - Investing.com
CONMED expands AirSeal compatibility to da Vinci 5 platform By Investing.com - Investing.com Canada
Intuitive’s 8mm hex cannula is now compatible with CONMED’s AirSeal - Stock Titan
CONMED (NYSE:CNMD) Faces A Crucial Robotics Test - Kalkine Media
Bessemer Group Inc. Purchases 36,940 Shares of CONMED Corporation $CNMD - MarketBeat
In 40 Robotic Prostatectomies, AirSeal Had Fewer Nociceptive Events per Hour - Stock Titan
CONMED (NYSE:CNMD) Stock Rating Upgraded by Wall Street Zen - MarketBeat
CNMD5600366 Bond Profile — Key Metrics - TradingView
Form 4 CONMED Corporation For: 17 July By Investing.com - Investing.com Nigeria
CONMED Corp (NYSE: CNMD) grants CFO stock options and RSUs - Stock Titan
CONMED (NYSE: CNMD) CFO John Gallagher reports zero common stock ownership - Stock Titan
ETFs Investing in CONMED Corporation Stocks - TradingView
Understanding Momentum Shifts in (CNMD) - Stock Traders Daily
CONMED (NYSE:CNMD) Faces A Tougher Market Test - Kalkine Media
CONMED Jumped 10%—Is This Takeover Rally Already Dangerous? - Smartkarma
Needham reiterates Hold on Conmed stock amid sale exploration - Investing.com
CONMED (CNMD) Stock Trades Up, Here Is Why - Yahoo! Finance Canada
CONMED (NYSE:CNMD) Sees Large Volume IncreaseWhat's Next? - MarketBeat
CNMD Jumps As Conmed Weighs Sale After PE Interest - StocksToTrade
Kimberly Lockwood Net Worth (2026) - GuruFocus
CNMD Jumps As Conmed Weighs Strategic Sale Options - timothysykes.com
CNMD Stock Surges As Much As 10% After-Hours On Reports Of Private Equity Takeover Interest - Yahoo Finance
Conmed shares jump on potential sale report By Investing.com - Investing.com Nigeria
A Look at Conmed Corp (CNMD) After 4.9% Gain -- GF Value $74.38 vs Price $38.48 - GuruFocus
CNMD Stock Pops As New CFO Arrives And Street Stays Cautious - timothysykes.com
Conmed shares jump on potential sale report - Investing.com
CONMED (NYSE:CNMD) Upgrade Puts Recovery In Focus - Kalkine Media
CONMED (NYSE:CNMD) Upgraded at BMO Capital Markets - MarketBeat
CONMED (NYSE:CNMD) Stock Price Up 11.6%Still a Buy? - MarketBeat
CNMD stock holds steady as focus shifts to the business - Ad-hoc-news.de
CONMED (CNMD) Stock Fair Value Moves Lower As Analysts Turn More Cautious - Yahoo Finance
CONMED stock centers on its medical device platform - ad-hoc-news.de
Conmed Corp Stock (CNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Conmed Corp Stock (CNMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Council LaVerne H | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
4,716 |
| Farkas Charles | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
15,527 |
| Kaye Mark | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
820 |
| Schwarzentraub Barbara J | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
5,012 |
| Lalomia Brent | Executive VP RA, QA |
Mar 06 '26 |
Option Exercise |
0.00 |
75 |
0 |
941 |
| Kaye Mark | Director |
Feb 24 '26 |
Option Exercise |
0.00 |
152 |
0 |
152 |
| Glaze Richard | Chief Information Officer |
Nov 21 '25 |
Sale |
41.21 |
257 |
10,591 |
0 |
| Glaze Richard | Chief Information Officer |
Nov 20 '25 |
Option Exercise |
0.00 |
375 |
0 |
375 |
1.04%
11.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):